Mirum Pharmaceuticals Inc... (MIRM)
NASDAQ: MIRM
· Real-Time Price · USD
50.30
0.67 (1.35%)
At close: Jun 16, 2025, 3:59 PM
1.35% (1D)
| Bid | 48 |
| Market Cap | 2.49B |
| Revenue (ttm) | 379.25M |
| Net Income (ttm) | -77.34M |
| EPS (ttm) | -1.61 |
| PE Ratio (ttm) | -31.24 |
| Forward PE | -100.02 |
| Analyst | Buy |
| Ask | 51.43 |
| Volume | 515,764 |
| Avg. Volume (20D) | 429,095 |
| Open | 49.76 |
| Previous Close | 49.63 |
| Day's Range | 49.33 - 50.35 |
| 52-Week Range | 27.10 - 54.23 |
| Beta | 0.95 |
About MIRM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MIRM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MIRM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.75%
Mirum Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
3 months ago
-7.01%
Mirum Pharmaceuticals shares are trading lower after the company reported a Q4 GAPP EPS miss.
1 month ago · businesswire.com
Mirum Pharmaceuticals to Participate in Upcoming Investor ConferencesFOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel the...
1 month ago · https://thefly.com
Mirum Pharmaceuticals price target raised by $4 at Raymond James, here's why29 May
1 month ago · seekingalpha.com
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2025 Earnings Call TranscriptMirum Pharmaceuticals, Inc. (NASDAQ:MIRM ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Andrew McKibben - SVP, Strategic Finance and IR Chris Peetz - CEO Peter Radovich...
